AZ has already made it clear its focus is on investing in the US market – which accounts for 30% of its sales – and started ...

Across our pipeline we have announced an unprecedented 16 positive Phase III trials this year, with four since our previous results including high-impact readouts for baxdrostat in hypertension and ...